ELECOM Transforms Charging in the U.S. with Japan’s Leading Wall Chargers
NEWPORT BEACH, Calif., April 24, 2024 (Newswire.com) - Renowned for creating the best-selling mobile and tablet accessories in Japan, ELECOM is now poised to transform the American charging solutions landscape with its cutting-edge, high-efficiency wall chargers. These chargers not only promise exceptional performance but also prioritize energy efficiency, thanks to their versatile, groundbreaking technology.
Since 2014, ELECOM has dominated the Japanese market as the top choice for wall chargers, alongside its diverse range of phone and tablet accessories. The brand has consistently been honored with the prestigious BCN Award for 10 years running, affirming its status as the premier choice for mobile charging solutions. With over 27 million chargers sold globally, ELECOM's expansion into the U.S. market marks a significant milestone. This introduction features a suite of advanced GaN II chargers, showcasing the latest advancements in wall charging technology.
Kazuya Hamaguchi, U.S. President and COO of ELECOM, expressed enthusiasm about the wall chargers’ U.S. debut, emphasizing the company's commitment to providing high-quality, customer-focused solutions. "Our design philosophy is deeply rooted in understanding and meeting consumer needs, positioning us as leaders in the charging market," Hamaguchi stated. "We are thrilled to offer our innovative charging solutions to American consumers."
The new ELECOM charger line-up includes eight models with power outputs ranging from 65W to 150W. These chargers feature one to four ports, allowing for simultaneous charging of multiple devices, from smartphones to laptops, ensuring compatibility and convenience.
Employing cutting-edge GaN II technology, these chargers are designed for maximum efficiency and compactness. They include smart Power Delivery (PD) and Programmable Power Supply (PPS) mechanisms, which intelligently optimize power distribution to the connected device, enabling rapid, efficient charging. The PD feature allows the charger to negotiate the optimal power draw with devices, ensuring quick and safe charging, while PPS adjusts power levels to precisely meet the device's charging needs, promoting optimal charging conditions.
Safety and durability are paramount in ELECOM's charger designs, which meet stringent safety standards and include features such as temperature detection and overcurrent protection. The chargers' durable, scratch-resistant, and smudge-proof exterior, coupled with GaN II technology, facilitates rapid charging in a travel-friendly form factor.
ELECOM has garnered over 200 design awards, reflecting its commitment to excellence in electronics and computer accessories. The brand has expanded its offerings to include products for home, kitchen, pets, and beauty, all while advancing its sustainability strategy to promote environmental and public safety through reduction, reuse, and recycling initiatives.
The new chargers retail for $49.99 to $99.99 and are now available for purchase on the ELECOM website and Amazon store.
About ELECOM USA
Since 1986, ELECOM has been at the forefront of innovation in consumer electronics, earning a global reputation for its modern design and exceptional quality. The brand boasts over 150 Good Design Awards and 66 IF Design Awards, underscoring its dedication to excellence and innovation in the tech accessories market.
Contact Information:Buse Kayar
[email protected]
Related Images
Original Source: ELECOM Transforms Charging in the U.S. with Japan's Leading Wall Chargers
Cactus Life Sciences Announces the Acquisition of nspm and eluSCIdate
PRINCETON, N.J., April 24, 2024 (Newswire.com) - Cactus Life Sciences, a leading global scientific communications agency that works with blue chip pharma and biotechnology companies, announced today that they have acquired nspm and eluSCIdate, two dynamic medical communications and publications companies headquartered in Meggen, Switzerland with an office in the UK.
Cactus Life Sciences, headquartered in Princeton, New Jersey, was formed in 2010 and is best known for its transformational global operating models that provide best in class science, innovation, and efficiency. Founded 27 years ago, nspm brings extensive expertise in medical communications, publications, and event management, with a focus on rare diseases. Its sister company eluSCIdate was founded in 2020 and focuses on medical and scientific publications, combining extensive experience in medical writing with creative flair to deliver high-quality publications.
This collaboration signifies a major step forward in enhancing services for our biopharma clients, ensuring a comprehensive and fully integrated global approach to medical communications. And provides a significant employee footprint in US, UK, Switzerland, and Japan.
“As Cactus Life Sciences embarks on its forthcoming buy-and-build strategy, we’re excited to unveil our first acquisition that shares so many of the same values as CACTUS, stated Oliver Dennis, the new Chairman of Cactus Life Sciences. “As we move forward, we seek partnerships that prioritize our people and clients alongside our strategic growth.”
Rare diseases individually affect a small number of people, but collectively affect over 300 million worldwide, presenting significant challenges for patients and medical professionals. nspm’s rare disease expertise addresses unmet needs for patients and society. Sabine Stotz, PhD, Managing Director, nspm, noted “This strategic alliance is a testament to the shared vision of excellence between Cactus Life Sciences, nspm and eluSCIdate. Together, our goal is to enrich the global landscape of scientific communications creating an even greater impact on healthcare professionals and the patients they treat.”
Elvira Dsouza, President, Cactus Life Sciences remarked, “Cactus Life Sciences stands out for its unwavering commitment to excellence, innovation, and future readiness. With a focus on integrating cutting-edge technology, notably AI, we aim to elevate scientific content creation to contribute to a more accessible, informed, and transformative healthcare landscape.”
About Cactus Life Sciences (cactuslifesciences.com): Cactus Life Sciences is a medical communication company that provides scientific strategy and content across the healthcare continuum, anywhere in the world ─ with a focus on science, innovation, and efficiency. We work alongside leading healthcare companies to establish the optimal role of medicines and encourage positive behaviors (physician and patient) that improve patient outcomes.
About nspm (www.nspm.com): nspm is a successful and dynamic medical communications company founded in 1997 with offices in Switzerland and the UK. nspm provides a complete range of medical writing, project management, and strategic medical communications solutions for the pharmaceutical and biotech industry across a range of therapeutic areas, with a focus on rare diseases. Our employees are committed to crafting high-quality, cost-effective solutions that exceed clients’ expectations through scientific excellence, professionalism, and creativity.
About eluSCIdate (www.eluscidate.com): eluSCIdate is a medical writing agency founded in 2020 that specializes in scientific publications, providing support for the entire publication process. We use a wealth of experience in medical writing to deliver high-quality manuscripts, posters, and slides to our clients. At eluSCIdate, we are passionate about science and committed to providing clarity in scientific messaging. Through effective communication, we work with our clients to ensure their science stands out from the crowd.
Contact Information:Laura Perry
VP of Strategy and Marketing
[email protected]
7327121005
Original Source: Cactus Life Sciences Announces the Acquisition of nspm and eluSCIdate
Cactus Life Sciences Announces the Acquisition of nspm and eluSCIdate
PRINCETON, N.J., April 24, 2024 (Newswire.com) - Cactus Life Sciences, a leading global scientific communications agency that works with blue chip pharma and biotechnology companies, announced today that they have acquired nspm and eluSCIdate, two dynamic medical communications and publications companies headquartered in Meggen, Switzerland with an office in the UK.
Cactus Life Sciences, headquartered in Princeton, New Jersey, was formed in 2010 and is best known for its transformational global operating models that provide best in class science, innovation, and efficiency. Founded 27 years ago, nspm brings extensive expertise in medical communications, publications, and event management, with a focus on rare diseases. Its sister company eluSCIdate was founded in 2020 and focuses on medical and scientific publications, combining extensive experience in medical writing with creative flair to deliver high-quality publications.
This collaboration signifies a major step forward in enhancing services for our biopharma clients, ensuring a comprehensive and fully integrated global approach to medical communications. And provides a significant employee footprint in US, UK, Switzerland, and Japan.
“As Cactus Life Sciences embarks on its forthcoming buy-and-build strategy, we’re excited to unveil our first acquisition that shares so many of the same values as CACTUS, stated Oliver Dennis, the new Chairman of Cactus Life Sciences. “As we move forward, we seek partnerships that prioritize our people and clients alongside our strategic growth.”
Rare diseases individually affect a small number of people, but collectively affect over 300 million worldwide, presenting significant challenges for patients and medical professionals. nspm’s rare disease expertise addresses unmet needs for patients and society. Sabine Stotz, PhD, Managing Director, nspm, noted “This strategic alliance is a testament to the shared vision of excellence between Cactus Life Sciences, nspm and eluSCIdate. Together, our goal is to enrich the global landscape of scientific communications creating an even greater impact on healthcare professionals and the patients they treat.”
Elvira Dsouza, President, Cactus Life Sciences remarked, “Cactus Life Sciences stands out for its unwavering commitment to excellence, innovation, and future readiness. With a focus on integrating cutting-edge technology, notably AI, we aim to elevate scientific content creation to contribute to a more accessible, informed, and transformative healthcare landscape.”
About Cactus Life Sciences (cactuslifesciences.com): Cactus Life Sciences is a medical communication company that provides scientific strategy and content across the healthcare continuum, anywhere in the world ─ with a focus on science, innovation, and efficiency. We work alongside leading healthcare companies to establish the optimal role of medicines and encourage positive behaviors (physician and patient) that improve patient outcomes.
About nspm (www.nspm.com): nspm is a successful and dynamic medical communications company founded in 1997 with offices in Switzerland and the UK. nspm provides a complete range of medical writing, project management, and strategic medical communications solutions for the pharmaceutical and biotech industry across a range of therapeutic areas, with a focus on rare diseases. Our employees are committed to crafting high-quality, cost-effective solutions that exceed clients’ expectations through scientific excellence, professionalism, and creativity.
About eluSCIdate (www.eluscidate.com): eluSCIdate is a medical writing agency founded in 2020 that specializes in scientific publications, providing support for the entire publication process. We use a wealth of experience in medical writing to deliver high-quality manuscripts, posters, and slides to our clients. At eluSCIdate, we are passionate about science and committed to providing clarity in scientific messaging. Through effective communication, we work with our clients to ensure their science stands out from the crowd.
Contact Information:Laura Perry
VP of Strategy and Marketing
[email protected]
7327121005
Original Source: Cactus Life Sciences Announces the Acquisition of nspm and eluSCIdate
